Investment in Promethera Biosciences

Advising Japanese investment fund CELL INNOVATION PARTNERS INC. on the acquisition of a stake in the biotech company PROMETHERA BIOSCIENCES, a leader in the development of innovative therapies for the treatment of liver diseases. The van Cutsem team was led by Benjamin Haberkorn and Didier Leclercq (November 2016).